The University of California, Irvine’s (UC Irvine) Institute for Clinical & Translational Science has received a grant of $24m from the National Institutes of Health.
The funding is part of NIH’s Clinical & Translational Science Awards programme and will be awarded over five years.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The institute will use this grant to start new research and to accelerate scientific discoveries into medical advances.
School of Medicine dean Dr Michael J Stamos said: “As a top public research university and a major healthcare provider in Orange County, it is our mission at UCI to dedicate ourselves to supporting and encouraging the translation of biomedical research into new and better cures and treatments.”
ICTS director Dr Dan M Cooper said: “With this award, the institute will continue to lead the development of innovative approaches. It will also enable us to expand the reach of our work to diverse communities, setting new standards for clinical research in the US for a generation to come.”
The institute intends to use the money to train the next generation of clinical researchers and increase the involvement of special populations in its clinical trials.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataSpecial populations refer to the homeless, children, elderly, veterans and the Asian and Latino communities.
The fund will also be used by the institute to create a clinical data warehouse.
It also plans to use robotics in the rehabilitation of patients and further discoveries into the physical fitness at school, which has the potential to improve health in the long run.
The UC Irvine is the first institution to win the award in Orange County and the seventh in the state of California.
